Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients

Volume: 34, Issue: 1, Pages: 167 - 174
Published: Jul 14, 2021
Abstract
COPD is a common chronic condition in older age that impacts on daily activities and quality of life. Previous studies suggest that magnesium deficit in COPD patients affects bronco-obstruction, inflammation, and physical performance. We investigated whether oral magnesium supplementation in stable-phase COPD patients improves lung function, physical performance, and quality of life.We conducted a double-blind randomized-controlled clinical...
Paper Details
Title
Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients
Published Date
Jul 14, 2021
Volume
34
Issue
1
Pages
167 - 174
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.